Maniakas, A., Cognetti, D., Tahara, M., Makino, T., Chang, K., Homma, A., Wang, C., Huang, C., Kantharia, D. R., Mifsud, M. J., Panjwani, G., Hanai, N., Danesi, H., Suzuki, T., Chen, S. E., Dong, H., Imamura, D., Cheng, R., Gillenwater, A. M., Lou, P. (2026). A phase 3, randomized, double-arm, open-label, controlled study of ASP-1929 photoimmunotherapy (PIT) versus physician’s choice standard of care (SOC) for patients with locoregional, recurrent head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6080